Biodegradabiliy of spherical mesoporous silica particles (MCM-41) in simulated body fluid (SBF)

被引:5
作者
Boccardi, Elena [1 ]
Philippart, Anahi [1 ]
Beltran, Ana M. [2 ,4 ]
Schmidt, Jochen [3 ]
Liverani, Liliana [1 ]
Peukert, Wolfgang [3 ]
Boccaccini, Aldo R. [1 ]
机构
[1] Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, D-91058 Erlangen, Germany
[2] Univ Seville, CSIC, Inst Ciencia Mat Sevilla, Seville 41092, Spain
[3] Univ Erlangen Nurnberg, Inst Particle Technol, Dept Chem & Biol Engn, D-91058 Erlangen, Germany
[4] Univ Seville, Dept Ingn & Ciencia Mat & Transporte, Seville 41092, Spain
关键词
Mesoporous silica particles; Simulated body fluid; Biodegradability; Bone tissue engineering; Drug carriers; Biomaterials-Mineralogy Meets Medicine; GLASS-CERAMICS; DRUG-DELIVERY; SPHERES; BIOACTIVITY; 45S5;
D O I
10.2138/am-2018-6281
中图分类号
P3 [地球物理学]; P59 [地球化学];
学科分类号
0708 ; 070902 ;
摘要
Mesoporous silica particles of type MCM-41 (Mobile Composition of Matter No. 41), exhibiting highly ordered mesoporosity (pores with diameter between 2 and 50 nm) and surface roughness, are developed and used as a functional coating on bioactive glass-based scaffolds for bone tissue engineering. The degradability and the mesostructure stability of these novel MCM-41 particles were evaluated. The particles are immersed in simulated body fluid (SBF) for up to 28 days at 37 degrees C, and the variation of the ordered porosity, surface characteristics, and chemical composition of the particles are assessed by SEM-EDX, HRTEM, FTIR, ICP-OES, and pH measurements. The results indicate that the MCM-41 particles are affected by immersion in SBF only during the first few days; however, the surface and the mesopore structure of the particles do not change further with increasing time in SBF. The pore channel diameter increased slightly, confirming the stability of the developed material. The release of dissolved Si-species, which reached a maximum of 260 mg SiO2 per gram of material, could play a key role in gene activation of osteoblast cells and in inducing new bone matrix formation. Keywords: Mesoporous silica particles, Simulated body fluid, Biodegradability, Bone tissue
引用
收藏
页码:350 / 354
页数:5
相关论文
共 22 条
  • [1] Beck J. S., 1992, U.S. Patent, Patent No. [50,108,725, 50108725]
  • [2] Boccardi E, 2016, THESIS
  • [3] Uniform surface modification of 3D Bioglass®-based scaffolds with mesoporous silica particles (McM-41) for enhancing drug delivery capability
    Boccardi, Elena
    Philippart, Anahi
    Juhasz-Bortuzzo, Judith A.
    Beltran, Ana M.
    Novajra, Giorgia
    Vitale-Brovarone, Chiara
    Spiecker, Erdmann
    Boccaccini, Aldo R.
    [J]. FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2015, 3
  • [4] Dilute solution routes to various controllable morphologies of MCM-41 silica with a basic medium
    Cai, Q
    Luo, ZS
    Pang, WQ
    Fan, YW
    Chen, XH
    Cui, FZ
    [J]. CHEMISTRY OF MATERIALS, 2001, 13 (02) : 258 - 263
  • [5] Effect of pH and ionic strength on the reactivity of Bioglass® 45S5
    Cerruti, M
    Greenspan, D
    Powers, K
    [J]. BIOMATERIALS, 2005, 26 (14) : 1665 - 1674
  • [6] The synthesis of micrometer- and submicrometer-size spheres of ordered mesoporous oxide MCM-41
    Grun, M
    Lauer, I
    Unger, KK
    [J]. ADVANCED MATERIALS, 1997, 9 (03) : 254 - &
  • [7] Novel pathways for the preparation of mesoporous MCM-41 materials:: control of porosity and morphology
    Grün, M
    Unger, KK
    Matsumoto, A
    Tsutsumi, K
    [J]. MICROPOROUS AND MESOPOROUS MATERIALS, 1999, 27 (2-3) : 207 - 216
  • [8] The story of Bioglass®
    Hench, Larry L.
    [J]. JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2006, 17 (11) : 967 - 978
  • [9] In vitro stability of SBA-15 under physiological conditions
    Izquierdo-Barba, I.
    Colilla, M.
    Manzano, M.
    Vallet-Regi, M.
    [J]. MICROPOROUS AND MESOPOROUS MATERIALS, 2010, 132 (03) : 442 - 452
  • [10] How useful is SBF in predicting in vivo bone bioactivity?
    Kokubo, T
    Takadama, H
    [J]. BIOMATERIALS, 2006, 27 (15) : 2907 - 2915